29 mars 2024

Pfizer: oral pill prevents damage from Omicron variant

Partager avec :

Pfizer is increasingly leading the war against COVID-19. It announced on Tuesday that laboratory studies show that its oral pill is effective against Covid-19. It may help protect against severe disease caused by the new coronavirus, including the Omicron variant.

The tests were done on high-risk patients

According to the researchers, PAXLOVID reduces the risk of hospitalisation or death by 89% within three days of symptom onset. The figures drop to 88% if the patient is within 5 days of symptom onset. "No deaths compared to placebo in high-risk adults not hospitalised on Covid-19," the statement said.

MamP's

© Crédit Photos : Les Echos